“Maintenance of Response to Risankizumab in Patients With Psoriatic Arthritis: A 3-year Analysis of the KEEPsAKE 1 and 2 Trials” (2023) SKIN The Journal of Cutaneous Medicine, 7(6), p. s249. doi:10.25251/skin.7.supp.249.